Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 67, Issue 5, Pages 1674-1687Publisher
SPRINGER
DOI: 10.1007/s10620-022-07393-z
Keywords
Bariatric Endoscopy; EBMTs; Obesity; ESG; POSE; IGB
Categories
Ask authors/readers for more resources
Obesity is a pandemic with various treatment options available, including lifestyle modification, pharmacotherapy, endoscopic bariatric and metabolic therapy, and bariatric surgery. Gastroenterologists need to be familiar with these treatments in order to guide patients in selecting the appropriate therapy. This chapter reviews the currently available and upcoming treatment methods.
Obesity is pandemic. It is estimated that by 2030, half of the U.S. population will have obesity. Current treatment options for obesity includes lifestyle modification, pharmacotherapy, endoscopic bariatric and metabolic therapy (EBMT) and bariatric surgery. Over the past decades, an increasing number of EBMTs have been developed and become available. As a gastroenterologist, it is therefore important to become familiar with the available EBMTs as well as their safety and efficacy profiles in order to educate and expeditiously refer patients for the appropriate therapy when eligible. This chapter will review currently available and upcoming EBMTs. Details on how the procedures are performed, their mechanisms of action as well as data from pivotal studies will be summarized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available